News

GSK, iTeos take stock after Roche’s TIGIT setback

Phil Taylor GlaxoSmithKline, iTeos Therapeutics, Roche, TIGIT, tiragolumab 0 Comment

iTeos Therapeutics has said it is evaluating with partner GlaxoSmithKline whether to conduct additional clinical trials of TIGIT

GSK, iTeos take stock after Roche’s TIGIT setback

https://pharmaphorum.com/news/gsk-iteos-take-stock-after-roches-tigit-setback/

News/ News/ Oncology

BMS doubles down on BridgeBio alliance on SHP2 drugs

Phil Taylor BridgeBio Pharma, Bristol-Myers Squibb, immuno-oncology, Oncology, Opdivo, partnering, SHP2 0 Comment

Bristol-Myers Squibb’s flurry of dealmaking has continued with en expansion of its partnership with BridgeBio on drugs targeting

BMS doubles down on BridgeBio alliance on SHP2 drugs

https://pharmaphorum.com/news/bms-doubles-down-on-bridgebio-alliance-on-shp2-drugs/

News/ News/ News/ Oncology/ R&D

Roche’s TIGIT ambitions take another blow

Phil Taylor immuno-oncology, Non-small cell lung cancer, Oncology, Roche, TIGIT, tiragolumab 0 Comment

Roche’s anti-TIGIT antibody tiragolumab has failed a second phase 3 trial, dousing expectations for the programme and its

Roche’s TIGIT ambitions take another blow

https://pharmaphorum.com/news/roches-tigit-ambitions-take-another-blow/

Digital/ News/ News/ News/ Oncology

Roche extends Kaiku digital monitoring partnership again

Phil Taylor digital, digital health, Kaiku Health, partnering, patient monitoring, Roche 0 Comment

Roche has elevated a longstanding alliance with Finland’s Kaiku Health focusing on digital patient monitoring and management (DPMM)

Roche extends Kaiku digital monitoring partnership again

https://pharmaphorum.com/news/roche-extends-kaiku-digital-monitoring-partnership-again/

News/ News/ News/ Oncology/ R&D

Nykode vaccine shows its worth in cervical cancer trial

Phil Taylor cancer vaccine, cervical cancer, HPV, immuno-oncology, Nykode Therapeutics, Oncology, Vaccibody 0 Comment

Adding Nykode Therapeutics’ VB10.16 vaccine to treatment with Roche’s cancer immunotherapy Tecentriq resulted in disease control in two-thirds

Nykode vaccine shows its worth in cervical cancer trial

https://pharmaphorum.com/news/nykode-vaccine-shows-its-worth-in-cervical-cancer-trial/

Digital/ News/ News/ News/ News/ Oncology/ Patients

Game used to track symptoms in children with cancer

Phil Taylor digital, digital health, games for health, Oncology, paediatrics, patients 0 Comment

A study has shown that a mobile game can be used to gather symptom data from children undergoing

Game used to track symptoms in children with cancer

https://pharmaphorum.com/news/game-used-to-track-symptoms-in-children-with-cancer/

News/ News/ News/ Oncology/ Sales and Marketing

Manufacturing foul-up hits Novartis’ radioligand business

Phil Taylor Lutathera, manufacturing, Novartis, Oncology, Pluvicto, Radiopharmaceutical 0 Comment

Novartis has shut down production of its radioligand therapies – one of its key growth areas – at

Manufacturing foul-up hits Novartis’ radioligand business

https://pharmaphorum.com/news/manufacturing-foul-up-hits-novartis-radioligand-business/

Market Access/ News/ News/ News/ Oncology

AZ eyes Q3 FDA decision for Imfinzi in biliary tract cancer

Phil Taylor AstraZeneca, biliary tract cancer, Imfinzi, immuno-oncology, Oncology 0 Comment

The FDA has kicked off a priority review of AstraZeneca’s checkpoint inhibitor Imfinzi for biliary tract cancer (BTC),

AZ eyes Q3 FDA decision for Imfinzi in biliary tract cancer

https://pharmaphorum.com/news/az-eyes-q3-fda-decision-for-imfinzi-in-biliary-tract-cancer/

Market Access/ News/ News/ News/ Oncology

Kymriah is first CAR-T cleared for follicular lymphoma in EU

Phil Taylor CAR-T therapies, cell therapy, Gilead Sciences, immuno-oncology, Kymriah, Novartis, Oncology, regulatory approval, Yescarta 0 Comment

Novartis’ CAR-T Kymriah has become the first therapy in the category to be approved for the treatment of

Kymriah is first CAR-T cleared for follicular lymphoma in EU

https://pharmaphorum.com/news/kymriah-is-first-car-t-cleared-for-follicular-lymphoma-in-eu/

1 2 3 4 ›»

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com

Trending

News

Login